Search

SALES SPECIALIST- CARDIOVASCULAR- OCEANSIDE CA - NOVARTIS - LA JOLLA, CA

Experience in the promotion of cardiovascular pharmaceuticals / biotech products. Provides relevant, thoughtful input to other commercial...

Novartis stockpiles drugs amid Brexit supply chain concerns

NOVARTIS STOCKPILES DRUGS AMID BREXIT SUPPLY CHAIN CONCERNS

The Swiss drugmaker is concerned that a no-deal Brexit would disrupt delicate supply chains and urged the UK and EU to provide clarity...

 
 
 

SWISS TEAM STOPS BREAST CANCER METASTASIS BY FOOLING CELLS INTO BECOMING FAT

In mouse models of metastatic breast cancer, a combination of GlaxoSmithKline's diabetes drug Avandia and Novartis' cancer treatment...

Notes from the JPM19 Vortex: Price Apocalypse, Celgene Fallout & More

NOTES FROM THE JPM19 VORTEX: PRICE APOCALYPSE, CELGENE FALLOUT & MORE

[ Editor's note: Ben Fidler and Sarah de Crescenzo coauthored this report .] It is here, and then it is gone. But by the time everyone...

 
 
 
Tilray is soaring after announcing a deal with a unit of the Swiss drug giant Novartis to take its medical products global

TILRAY IS SOARING AFTER ANNOUNCING A DEAL WITH A UNIT OF THE SWISS DRUG GIANT NOVARTIS TO TAKE ITS MEDICAL PRODUCTS GLOBAL

Tilray announced Tuesday that it has partnered with a division of Swiss-drug giant Novartis AG to develop and distribute its medical...

15 For '19: Key Clinical Data to Watch For Next Year

15 FOR '19: KEY CLINICAL DATA TO WATCH FOR NEXT YEAR

On Monday, Xconomy began our annual look ahead at clinical trials that could define biotech and have profound healthcare effects in...

 
 
 
Bio Roundup: Eli Lilly Tries Tau, Generic Insulin, NASH Cash & More

BIO ROUNDUP: ELI LILLY TRIES TAU, GENERIC INSULIN, NASH CASH & MORE

Pharmaceutical industry critics lament the cost of rare disease drugs, but some of the steepest price hikes have come on widely used...

 
 
 

BIG PHARMA RIVALS PFIZER AND NOVARTIS TEAM UP ON NASH COMBO TARGETS

Pfizer is joining forces with Novartis with a "throw it all at the wall and see what sticks" approach as they look to combine NASH...

 
 
 

ESMO18: NOVARTIS PI3K COMBO THERAPY BOOSTS SURVIVAL IN SUBSET OF BREAST CANCER PATIENTS

Novartis has come out with data at this year's European cancer congress ESMO with positive results from a phase 3 looking at its investigational...

Bio Roundup: Prices on TV, Novartis Hearts Radio, Warp Drive's End

BIO ROUNDUP: PRICES ON TV, NOVARTIS HEARTS RADIO, WARP DRIVE'S END

Two new battlegrounds emerged this week in the nation's ongoing drug pricing debate. The first involved television: The federal government...

 
 
 
Cancer-therapy provider Endocyte spikes 50% after Novartis agrees to buy it for $2.1 billion

CANCER-THERAPY PROVIDER ENDOCYTE SPIKES 50% AFTER NOVARTIS AGREES TO BUY IT FOR $2.1 BILLION

Novartis , the Swiss drug maker, has agreed to buy the US cancer-treatment provider Endocyte , for $2.1 billion. Under the agreement,...

What It's Really Like To Live With Metastatic Breast Cancer

WHAT IT'S REALLY LIKE TO LIVE WITH METASTATIC BREAST CANCER

Branded - Novartis: Cancer Can Kiss This Episode 1 Breast cancer awareness is so much more than pink ribbons, painted bras, and feather...

 
 
 
Bio Roundup: Nobel Prizes, Duchenne Steps, Guardant's IPO & More

BIO ROUNDUP: NOBEL PRIZES, DUCHENNE STEPS, GUARDANT'S IPO & MORE

Cancer immunotherapy is all the rage these days. The idea of harnessing the immune system to treat cancer has sparked billions of dollars...

NOVARTIS-BACKED CELL THERAPY STARTUP GAMIDA FILES FOR IPO

Gamida Cell has filed to raise $69 million in a Nasdaq IPO. The Novartis-backed cell therapy player wants the money to wrap up a phase...

 
 
 
Drugmakers are using an unusual tactic to compete in a new class of medication - giving it away for free

DRUGMAKERS ARE USING AN UNUSUAL TACTIC TO COMPETE IN A NEW CLASS OF MEDICATION - GIVING IT AWAY FOR FREE

Since May, the FDA has approved three new drugs in a new class of preventive migraine medication: Aimovig, made by Amgen and Novartis;...

Bio Roundup: Amarin's Stunner, Lung Cancer News, Data Dumps & More

BIO ROUNDUP: AMARIN'S STUNNER, LUNG CANCER NEWS, DATA DUMPS & MORE

Six years ago, a biotech called Amarin won FDA approval of a prescription fish-oil pill, Vascepa, because it could lower triglycerides,...

 
 
 

SALES SPECIALIST- MS - SAN DIEGO CA - NOVARTIS - SAN DIEGO, CA

2 years was in a specialty pharmaceutical /biotech sales within the last 5 years. Interpersonal communication, organization & prioritization,...